Status:
COMPLETED
Piriformis Syndrome; Extracorporeal Shock Wave Therapy and Dry Needling
Lead Sponsor:
Istanbul Training and Research Hospital
Conditions:
Piriformis Syndrome
Extracorporeal Shock Wave Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being conducted on patients with piriformis syndrome. Patients are divided into two groups by list randomization method: Extracorporeal shock wave therapy (ESWT) group and Dry neddling (...
Eligibility Criteria
Inclusion
- \>18 years
- Complaint for more than 3 months
Exclusion
- disc pathologies according to radiological imaging
- hip joint and soft tissue pathologies
- recent history of trauma, history of surgery in the lumbar and hip region
- history of rheumatologic disease
- history of polyneuropathy
- history of sciatic nerve injury
- history of malignancy
- opioid analgesia or corticosteroid intervention for pain in the last month
- patients receive another treatment during the study
- Having a contraindication for DN treatment or ESWT treatment
Key Trial Info
Start Date :
February 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 23 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06530862
Start Date
February 3 2024
End Date
August 23 2024
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Burak Tayyip Dede
Istanbul, Turkey (Türkiye)